Session Details

Aneuploidy


Chair Beryl Benacerraf Harvard Medical School
Co-Chair Gary Pritchard Royal Women's Hospital - Brisbane
Nuchal translucency screening for chromosomal and other defects
  • Jon Hyett
  • Nuchal translucency screening - the Australian experience
  • Andrew McLennan
  • Second trimester markers of fetal chromosomal defects
  • David A Nyberg
  • Second trimester sonographic markers of aneuploidy-significance in unselected populations
  • Robert Ogle